| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PERNIX THERAPEUTICS HOLDINGS INC | 2,500,000 | 688,000 | 0.13% | PRN | |
| 2 | PERNIX THERAPEUTICS HLDGS IN | 210,000 | 777,000 | 0.14% | ||
| 3 | CHIMERIX INC | 472,943 | 3,017,000 | 0.55% | ||
| 4 | Intersect ENT Inc | 225,000 | 3,859,000 | 0.70% | ||
| 5 | Agile Therapeutics, Inc. | 1,804,933 | 5,776,000 | 1.05% | ||
| 6 | CIDARA THERAPEUTICS INC | 1,021,148 | 7,965,000 | 1.45% | ||
| 7 | SYROS PHARMACEUTICALS INC | 508,565 | 8,101,000 | 1.47% | ||
| 8 | PARATEK PHARMACEUTICALS INC | 482,680 | 9,292,000 | 1.69% | ||
| 9 | TRANSENTERIX INC | 8,335,819 | 10,086,000 | 1.84% | ||
| 10 | T2 BIOSYSTEMS INCORPORATED | 2,830,992 | 14,891,000 | 2.71% | ||
| 11 | ADMA BIOLOGICS, INC. | 3,608,171 | 17,608,000 | 3.21% | ||
| 12 | Esperion Therapeutics Inc | 837,125 | 29,559,000 | 5.38% | ||
| 13 | VERSARTIS INC | 2,024,465 | 43,222,000 | 7.87% | ||
| 14 | VIEWRAY INC COM USD0.01 | 7,480,887 | 63,662,000 | 11.59% | ||
| 15 | AIMMUNE THERAPEUTICS INC COM | 2,990,000 | 64,973,000 | 11.83% | ||
| 16 | ZELTIQ AESTHETICS INC | 1,609,727 | 89,516,000 | 16.30% | ||
| 17 | LOXO ONCOLOGY INC COM | 4,188,920 | 176,270,000 | 32.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950142-17-000991, filed 2017.05.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
